Preventive but Not Late Amiloride Therapy Reduces Morbidity and Mortality of Lung Disease in βENaC-overexpressing Mice

Saved in:

Bibliographic Details
Published in:	American journal of respiratory and critical care medicine Vol. 178; no. 12; pp. 1245 - 1256
Main Authors:	ZHE ZHOU, TREIS, Diana, SCHUBERT, Susanne C, HARM, Maria, SCHATTERNY, Jolanthe, HIRTZ, Stephanie, DUERR, Julia, BOUCHER, Richard C, MALL, Marcus A
Format:	Journal Article
Language:	English
Published:	New York, NY American Thoracic Society 15-12-2008
Subjects:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Diseases of the respiratory system Intensive care medicine Medical sciences Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) u-Plasminogen activator Intensive care Potassium sparing diuretic Mucus Prevention Amiloride pharmacotherapy airway surface liquid Resuscitation Pancreatic disease Lung disease Serine endopeptidases Enzyme Respiratory disease Mortality Rodentia Enzyme inhibitor Metabolic diseases Cystic fibrosis Epithelium Morbidity Genetic disease epithelial Na+ channels Peptidases Vertebrata Mammalia Treatment Mouse Animal Hydrolases Digestive diseases
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	1073-449X 1535-4970
DOI:	10.1164/rccm.200803-442OC